Literature DB >> 12399451

Intracellular accumulation of antithrombin Morioka (C95R), a novel mutation causing type I antithrombin deficiency.

Yuki Tanaka1, Kazue Ueda, Tetsuo Ozawa, Nobuo Sakuragawa, Sadaki Yokota, Ryuichiro Sato, Shoji Okamura, Masashi Morita, Tsuneo Imanaka.   

Abstract

Antithrombin (AT) is a major plasma protease inhibitor with three intramolecular disulfide bonds, and its deficiency is associated with increased venous thrombosis. Recently, we found a novel missense mutation named AT Morioka (C95R), which causes the loss of one of the three disulfide bonds. In this study, we prepared Chinese hamster ovary cells stably overexpressing wild type or mutant AT and examined the intracellular fate of the ATs. In pulse-chase experiments, newly synthesized wild type AT was secreted into the medium with a half-life of approximately 1.5 h. In contrast, most of the mutant type AT was not secreted during the chase period of 9 h and, surprisingly, was not degraded in the cells. The kinetics of the secretion suggests that the mutant was secreted about 50 times more slowly into the medium. Most of the mutant AT in the cells had high mannose type oligosaccharides, suggesting that it was retained in the endoplasmic reticulum (ER). In addition, half of the mutant AT existed in a dimeric form with an intermolecular disulfide bond. On immunoelectron microscopy, the mutant AT was found to have accumulated in variously sized structures surrounded by a single membrane in the cytoplasm. Immunogold particles exhibiting calnexin immunoreactivity were detected on the membranes. Ribosomes were attached to some of the small structures that had accumulated the mutant AT. Further, we prepared Chinese hamster ovary cells stably overexpressing another mutant AT in which two cysteine residues at 21 and 95, responsible for disulfide bond formation, were substituted for arginines. In pulse-chase experiments, the mutant AT (C21C,C95R) was secreted faster than that of AT Morioka (C95R) into the medium. These results suggest that AT Morioka remained for a long time in ER without being degraded and accumulated in newly formed membrane structures derived from the ER. The dimerization of AT Morioka (C95R) through Cys-21 seems to be critical for its intracellular accumulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399451     DOI: 10.1074/jbc.M210231200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport.

Authors:  Lena Tjeldhorn; Nina Iversen; Kirsten Sandvig; Jonas Bergan; Per Morten Sandset; Grethe Skretting
Journal:  BMC Cell Biol       Date:  2010-09-06       Impact factor: 4.241

2.  Deciphering the role of trehalose in hindering antithrombin polymerization.

Authors:  Asma Naseem; Mohammad Sazzad Khan; Hashim Ali; Irshad Ahmad; Mohamad Aman Jairajpuri
Journal:  Biosci Rep       Date:  2019-04-05       Impact factor: 3.840

3.  [Phenotypic and genetic analysis of a pedigree with inherited antithrombin deficiency].

Authors:  Q Y Xu; Y H Jin; X Y Zheng; L L Yang; X L Li; H Y Zhang; M S Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14

4.  Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.

Authors:  Réka Gindele; Krisztina Pénzes-Daku; Gábor Balogh; Judit Kállai; Réka Bogáti; Bálint Bécsi; Ferenc Erdődi; Éva Katona; Zsuzsanna Bereczky
Journal:  Biomolecules       Date:  2021-04-08

5.  ERAD of proteins containing aberrant transmembrane domains requires ubiquitylation of cytoplasmic lysine residues.

Authors:  Kit Briant; Yee-Hui Koay; Yuka Otsuka; Eileithyia Swanton
Journal:  J Cell Sci       Date:  2015-10-07       Impact factor: 5.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.